Menu:

Latest news:

September 2007:
The United States FDA grants IND Exception status to the discoverers of GIFT and approves a go-ahead of formal human trials!

July 2007:
Crystal Clear China-Global Development is honored by Munogenics LLC of America, by being asked to be involved in Munogenics quest to change the way the world treats cancer!

News:

January 1. 2007:
Formal incorporation of Crystal Clear China Global Development Ltd. HK.

January 8 2007:
CCCGD signs agreement with Mr. Liu Jun Jie, one of China's re-emerging - and growing more respected daily - crop of artists, to introduce his Chinese Brush, Ink and Watercolor on (Xuan) paper paintings to the international community! Mr Liu paints his ink and watercolor art in his own unique style, created over years of research and experimentation.

An Honor, Indeed!

In July 2007, Munogenics LLC of the United States of America, invited Crystal Clear China-Global Development Ltd. to participate in their project to change the world!

Crystal Clear China-Global Development Ltd. has now been named "Asian Representative" for the GIFT that Munogenics and their research partners are bringing to humankind!

GIFT stands for Granulocyte InFusion Therapy and is the world's first, truly effective treatment for cancer! It also stands for the most vital aspect of the discovery - the GIFT ASSAY TEST.

Beginning with a serendipitous discovery in 1999 by researchers at a well-known American university school of medicine, the development of this GIFT will soon be available to humankind.

"What is GIFT?"

GIFT is a treatment for cancer that for the first time in human history has already shown total cure of specific cancers (sarcoma, prostate cancer, skin cancer) in mice and that is set to begin human studies this year. We know it sounds remarkable, and it truly is! Over the last 8 years researchers have been building on the serendipitous discovery that led to not only the development of GIFT but also of the GIFT ASSAY TEST, that can identify if one is resistant to cancers (CR or Cancer Resistant) - or not. These two amazing discoveries WILL change the world of medicine in relation to the treatment of cancers!

The "KEY" to the door leading to the future of cancer treatment is the GIFT ASSAY TEST. It is this patented and proprietary discovery that can identify if a human or animal is, or is not, resistant to cancers...and to which cancers the subject is resistant! Without this "KEY" treatment using the GIFT is not possible.

With the benefit of the GIFT ASSAY TEST, a new chapter in assessing Risk and thus allowing a new kind of informed Risk Management has arrived. A completely revolutionary method, using a CR subject's "OWN" natural resistance to cancer to be cryogenically saved and returned to the CR subject when they are at an age when their natural resistance to cancer wanes, only adds to this amazing GIFT!

Think of the amazing possibilities! A truly natural, non-toxic method of treatment that has already proven itself over the last 8 years to actually effectively deal with cancer!

The possibilities in the human medicine, pet/veterinary, and animal husbandry industries almost staggers the mind!

Currently funding is being sought for full development and the beginning of Phase II and Phase III trials to be held in the United States and other countries and to establish laboratories that will provide the GIFT ASSAY TEST:

Further information can be obtained by serious, interested parties by contacting us.

Scientific information can be obtained only after signing of a Confidentiality and Non-Disclosure Agreement, although information is available on the internet and through publications such as PNAS (Proceedings of the National Academy of Sciences - www.pnas.org/).

You will notice we only provide two links from this page: our Home page and our Contact page. If you would like to visit our other pages please find links to those pages from our Home page.